Literature DB >> 9365239

Regulation of the tyrosine kinase substrate Eps8 expression by growth factors, v-Src and terminal differentiation.

R Gallo1, C Provenzano, R Carbone, P P Di Fiore, L Castellani, G Falcone, S Alemà.   

Abstract

SH3-containing proteins are involved in signal transduction by a number of growth factor receptors and in the organization of the cytoskeleton. The recently identified Eps8 protein, which contains an SH3 domain, is coupled functionally and physically to the EGFR and is tyrosine phosphorylated by this receptor and other receptors as well. Here, we examined the regulation of eps8 expression in response to mitogenic or differentiative signals. We show that Eps8 is expressed at low levels in resting fibroblasts, but its expression is strongly induced during activation by serum, phorbol esters and the v-src oncogene. Conversely, expression of Eps8, but not of other EGFR substrates such as Shc or Eps15, is virtually extinguished in non-proliferating, terminally differentiated murine myogenic cells. The putative role of Eps8 protein as a v-Src substrate was analysed in murine fibroblasts and in quail myogenic cells expressing a temperature-sensitive variant of the tyrosine kinase. Tyrosine phosphorylation of Eps8 was detected only at the permissive temperature. A non-myristylated, transformation-defective mutant of v-Src did not phosphorylate Eps8, whereas it phosphorylated Shc. Together, these findings indicate that Eps8 may be a critical substrate of v-Src. They further establish Eps8 as an example of a signal transducer whose expression senses the balance between growth and differentiation and might, therefore, be involved in the determination of the phenotype.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9365239     DOI: 10.1038/sj.onc.1201344

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Cell fate-specific regulation of EGF receptor trafficking during Caenorhabditis elegans vulval development.

Authors:  Attila Stetak; Erika Fröhli Hoier; Assunta Croce; Giuseppe Cassata; Pier Paolo Di Fiore; Alex Hajnal
Journal:  EMBO J       Date:  2006-05-11       Impact factor: 11.598

Review 2.  Targeting tumor cell motility to prevent metastasis.

Authors:  Trenis D Palmer; William J Ashby; John D Lewis; Andries Zijlstra
Journal:  Adv Drug Deliv Rev       Date:  2011-06-02       Impact factor: 15.470

3.  c-Jun N-terminal kinase 2 (JNK2) enhances cell migration through epidermal growth factor substrate 8 (EPS8).

Authors:  Shreya Mitra; Ju-Seog Lee; Michael Cantrell; Carla Lynn Van den Berg
Journal:  J Biol Chem       Date:  2011-02-28       Impact factor: 5.157

4.  Gene expression profile in prion protein-deficient fibroblasts in culture.

Authors:  J Satoh; Y Kuroda; S Katamine
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

5.  Transcriptional profile of Rous Sarcoma Virus transformed chicken embryo fibroblasts reveals new signaling targets of viral-src.

Authors:  Kathryn Masker; Alicia Golden; Christian J Gaffney; Virginia Mazack; William F Schwindinger; Weizhou Zhang; Lu-Hai Wang; David J Carey; Marius Sudol
Journal:  Virology       Date:  2007-04-19       Impact factor: 3.616

6.  Distinct effects of Rac1 on differentiation of primary avian myoblasts.

Authors:  R Gallo; M Serafini; L Castellani; G Falcone; S Alemà
Journal:  Mol Biol Cell       Date:  1999-10       Impact factor: 4.138

7.  Novel binding partners and differentially regulated phosphorylation sites clarify Eps8 as a multi-functional adaptor.

Authors:  Debbie L Cunningham; Andrew J Creese; Giulio Auciello; Steve M M Sweet; Tulin Tatar; Joshua Z Rappoport; Melissa M Grant; John K Heath
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

8.  Infectious bronchitis virus entry mainly depends on clathrin mediated endocytosis and requires classical endosomal/lysosomal system.

Authors:  Huan Wang; Xiao Yuan; Yingjie Sun; Xiang Mao; Chunchun Meng; Lei Tan; Cuiping Song; Xusheng Qiu; Chan Ding; Ying Liao
Journal:  Virology       Date:  2018-12-28       Impact factor: 3.616

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.